Iambic Therapeutics’ Post

📣 ICYMI📣 July's Resource Roundup includes: 📖 How to set up your CDMS/EDC to overcome staffing challenges and grow with you 📊 What other small biopharma orgs and CROs think about the latest eClinical trends 🏥 Meeting the regulatory push for Real-Time Oncology Review (RTOR) while executing mid-study changes Learn more here: https://bit.ly/3W2xbVT #EDC #CDMS #Oncology #Biotech #CRO #DataQuality #ClinicalDataManagement #ClinicalTrials

If you are a pioneering #biotech, #medicaldevice, or #diagnostics company, great insights in this month's Medrio Resource Roundup, including: - Thoughts on selecting technology to serve small teams and to extend your cash runway - Insight into the types of #clinicalresearch technologies that other #lifesciences companies are using as they evolve into #earlyphase trials

Join us on Feb. 8 when @Bill Byrom and @Anthony Todd Everhart will talk about recent updates to FDA guidances, practical applications of computerized adaptive tests (CATs), and leveraging PROs in early-phase oncology trials. Engage with industry experts, explore use cases, and gain practical tips for implementing PROMs throughout #oncology drug development (from early phase to phase III). Secure your spot today: https://lnkd.in/eMP5Xj-z #oncologytrials #eCOA #webinar #lifesciencesevents

More exciting news coming out of Treadwell Therapeutics!

🎗 Explore our robust library of oncology learning content. Pharmaceutical companies rely on our trusted Oncology: Treatment and Management and Oncology Business Acumen curriculums to train their teams. In response to the rise of precision medicine, we've also introduced three new eModules on Precision Medicine. Equip your client-facing teams with the latest knowledge and skills needed to excel in the evolving field of oncology. Chat with our training experts to learn more. https://lnkd.in/dZmk7bbP #CMRInstitute #yourCMR #lifesciences #healthcare #lifescienceindustry #healthcareindustry #healthcareeducation #oncology #precisionmedicine

What is the real impact of reducing clinical trial contracting cycle times? For one global biotech, it enabled them to bring life-saving cancer drugs to market 50% faster than before. At the same time, allowing them to plug revenue leaks associated with delayed clinical trial site start-up, while building a clear roadmap for scalable contracting in the future. Read the full story here: https://ow.ly/bT6F50Sm9vB

🌟 #Webinar This Thursday: Mastering Project Optimus in Oncology Drug Development Join us for a must-attend webinar on the FDA's Project Optimus and its implications for oncology drug development. 👉 Secure your spot: https://lnkd.in/eGhgEFSx Covering: 🔹 An introductory overview of Project Optimus 🔹 Its impact on oncology trials and drug development 🔹 Practical strategies for navigating the new regulatory framework The Experts: 🎙️ Giles Partington, Principal Statistician, Phastar 🎙️ Sam Hinsley, Principal Statistician, Phastar (Moderator) Don't miss out on this crucial opportunity to stay ahead in oncology drug development. Register today! #Oncology #DrugDevelopment #ProjectOptimus #FDA #ClinicalTrials #Webinar #Phastar

To run a successful oncology development program under the FDA's Project Optimus, it's crucial to focus on identifying the optimal dose range for your asset. In our latest blog, James Matcham and Mike Fossler provide valuable insights into Project Optimus and discuss key factors that can enhance your chances of success. Read the full article: https://bit.ly/3W8e2Dc #FDAProjectOptimus #FDA #Oncology #oncologydevelopment #clinicaltrials #optimaldose #drugdevelopment #pharma #biotech

Flow diagram of oncology drug approvals, testing of overall survival, and demonstrating overall survival. https://lnkd.in/dXACXuMm

J&J Dives Deeper into Oncology with $2B Ambrx Buyout, Enhancing ADC Portfolio Amid Pharma's Deal Spree at #JPM24. #HealthcareMergers #OncologyAdvancement #abts #abtsconventionservices #MedicalNews #MeetingsIndustry #BreakingNews